Clostridium Difficile (C Diff.) Study

    Not Recruiting
Updated on 22 September 2021


Effective treatment of C. diff infections is critical, but how do we prevent the problem of recurrences?
Recurrence of Clostridium difficile infection (CDI) is a key unmet medical need in the management of CDI:
-  Occurs in up to 30% of patients following initial therapy
-  Significant burden on patients due to increased morbidity and diminished quality of life
-  Associated with an increased risk of further recurrent episodes and an increase in severity
 Learn how to participate in the Ri-CoDIFy study investigating an antibiotic has the potential to not only effectively treat CDI but also to reduce disease recurrence typically seen with standard of care antibiotic treatments.


Qualified participants will receive:

    - Study-related medication at no cost - Study-related medical exams at no cost - Compensation for time and travel

Condition Clostridium Difficile-Associated Diarrhea
Clinical Study IdentifierTX223536
Last Modified on22 September 2021

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note